Lipidomics studies on macrophages - RAW 264.7 cells treated with Kdo2-Lipid A and compactin

Introduction | Browse | Search | Download
Mouse-over the above links for more information

Treatment details

LM ID Analyte Treatment Time(hrs) Sample ID Value Units
LMFA03010134 PGE1 cPLA2i 1.0 BCD110605C28 0.435 pmol/ml medium
LMFA03010134 PGE1 cPLA2i 1.0 BCD110605C30 0.587 pmol/ml medium
LMFA03010134 PGE1 cPLA2i 1.0 BCD110605C29 0.554 pmol/ml medium
LMFA03010134 PGE1 cPLA2i 20.0 BCD110605C64 0.722 pmol/ml medium
LMFA03010134 PGE1 cPLA2i 20.0 BCD110605C66 0.745 pmol/ml medium
LMFA03010134 PGE1 cPLA2i 20.0 BCD110605C65 0.667 pmol/ml medium
LMFA03010134 PGE1 PLDi 1.0 BCD110605C16 0.571 pmol/ml medium
LMFA03010134 PGE1 PLDi 1.0 BCD110605C17 0.772 pmol/ml medium
LMFA03010134 PGE1 PLDi 1.0 BCD110605C18 0.634 pmol/ml medium
LMFA03010134 PGE1 PLDi 20.0 BCD110605C54 0.624 pmol/ml medium
LMFA03010134 PGE1 PLDi 20.0 BCD110605C52 0.744 pmol/ml medium
LMFA03010134 PGE1 PLDi 20.0 BCD110605C53 0.794 pmol/ml medium
LMFA03010134 PGE1 KDO+cPLA2i 1.0 BCD110605C32 0.51 pmol/ml medium
LMFA03010134 PGE1 KDO+cPLA2i 1.0 BCD110605C31 0.561 pmol/ml medium
LMFA03010134 PGE1 KDO+cPLA2i 1.0 BCD110605C33 0.435 pmol/ml medium
LMFA03010134 PGE1 KDO+cPLA2i 20.0 BCD110605C68 0.71 pmol/ml medium
LMFA03010134 PGE1 KDO+cPLA2i 20.0 BCD110605C69 0.695 pmol/ml medium
LMFA03010134 PGE1 KDO+cPLA2i 20.0 BCD110605C67 0.676 pmol/ml medium
LMFA03010134 PGE1 KDO+PLDi 1.0 BCD110605C19 0.792 pmol/ml medium
LMFA03010134 PGE1 KDO+PLDi 1.0 BCD110605C20 0.681 pmol/ml medium
LMFA03010134 PGE1 KDO+PLDi 1.0 BCD110605C21 0.504 pmol/ml medium
LMFA03010134 PGE1 KDO+PLDi 20.0 BCD110605C56 0.785 pmol/ml medium
LMFA03010134 PGE1 KDO+PLDi 20.0 BCD110605C57 0.772 pmol/ml medium
LMFA03010134 PGE1 KDO+PLDi 20.0 BCD110605C55 0.908 pmol/ml medium
LMFA03010134 PGE1 KDO+ATP+cPLA2i 1.0 BCD110605C37 0.611 pmol/ml medium
LMFA03010134 PGE1 KDO+ATP+cPLA2i 1.0 BCD110605C38 0.63 pmol/ml medium
LMFA03010134 PGE1 KDO+ATP+cPLA2i 1.0 BCD110605C39 0.565 pmol/ml medium
LMFA03010134 PGE1 KDO+ATP+cPLA2i 20.0 BCD110605C74 0.664 pmol/ml medium
LMFA03010134 PGE1 KDO+ATP+cPLA2i 20.0 BCD110605C75 0.662 pmol/ml medium
LMFA03010134 PGE1 KDO+ATP+cPLA2i 20.0 BCD110605C73 0.647 pmol/ml medium
LMFA03010134 PGE1 KDO+ATP+PLDi 1.0 BCD110605C25 0.529 pmol/ml medium
LMFA03010134 PGE1 KDO+ATP+PLDi 1.0 BCD110605C27 0.535 pmol/ml medium
LMFA03010134 PGE1 KDO+ATP+PLDi 1.0 BCD110605C26 0.575 pmol/ml medium
LMFA03010134 PGE1 KDO+ATP+PLDi 20.0 BCD110605C61 0.976 pmol/ml medium
LMFA03010134 PGE1 KDO+ATP+PLDi 20.0 BCD110605C62 0.701 pmol/ml medium
LMFA03010134 PGE1 KDO+ATP+PLDi 20.0 BCD110605C63 0.752 pmol/ml medium
LMFA03010134 PGE1 KDO + ATP 1.0 BCD110605C15 0.675 pmol/ml medium
LMFA03010134 PGE1 KDO + ATP 1.0 BCD110605C14 0.614 pmol/ml medium
LMFA03010134 PGE1 KDO + ATP 1.0 BCD110605C13 0.604 pmol/ml medium
LMFA03010134 PGE1 KDO + ATP 20.0 BCD110605C49 0.951 pmol/ml medium
LMFA03010134 PGE1 KDO + ATP 20.0 BCD110605C50 0.792 pmol/ml medium
LMFA03010134 PGE1 KDO + ATP 20.0 BCD110605C51 0.768 pmol/ml medium
LMFA03010134 PGE1 KDO 1.0 BCD110605C08 0.533 pmol/ml medium
LMFA03010134 PGE1 KDO 1.0 BCD110605C07 0.495 pmol/ml medium
LMFA03010134 PGE1 KDO 1.0 BCD110605C09 0.488 pmol/ml medium
LMFA03010134 PGE1 KDO 20.0 BCD110605C45 0.74 pmol/ml medium
LMFA03010134 PGE1 KDO 20.0 BCD110605C44 0.538 pmol/ml medium
LMFA03010134 PGE1 KDO 20.0 BCD110605C43 0.732 pmol/ml medium
LMFA03010134 PGE1 C 0.0 BCD110605C03 0.178 pmol/ml medium
LMFA03010134 PGE1 C 0.0 BCD110605C01 - pmol/ml medium